Advertisements



Northland starts $7 Oncternal Therapeutics at Outperform with $21 target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 23rd, 2021

Northland starts Zynex at Outperform on pain management potential

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2020

Target Hospitality downgraded to Market Perform from Outperform at Northland

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2020

Benchmark starts Voyager Therapeutics at Buy with $18 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 19th, 2020

AMD stock rises after analyst upgrade

Advanced Micro Devices Inc. shares are up 8.4% in premarket trading Friday after Northland Capital Markets analyst Gus Richard upgraded the stock to outperform from market perform while raising his price target on the sh.....»»

Category: topSource: marketwatchMar 13th, 2020

Citi starts Sage Therapeutics with Buy rating, $71 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 6th, 2020

Guggenheim starts Neoleukin Therapeutics at Buy with $20 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 18th, 2020

Guggenheim starts NeuBase Therapeutics at Buy with $13 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 7th, 2020

Oppenheimer starts Helen of Troy at Outperform with $210 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 5th, 2020

Oppenheimer starts Voyager Therapeutics at Outperform on Parkinson"s potential

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 5th, 2020

Baird starts "undervalued" Immunovant with Outperform, $21 target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2020

Wedbush starts Iveric bio with Outperform rating, $13 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 6th, 2020

Stoke Therapeutics started at outperform with $31 stock price target at Wedbush

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchDec 18th, 2019

Raymond James starts Purple Innovation at Outperform with $11 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 26th, 2019

Raymond James starts Meridian Bancorp at Outperform with $22 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 26th, 2019

NeuBase Therapeutics started at outperform with $14 stock price target at Oppenheimer

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchNov 21st, 2019

Guggenheim starts CytomX Therapeutics with Buy rating, $16 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 20th, 2019

Oppenheimer starts Dana with Outperform rating, $20 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 19th, 2019

Oppenheimer starts "RNAi juggernaut" Alnylam at Outperform with $128 target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 19th, 2019

RBC starts Sonos with Outperform rating, $18 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2019

RBC starts Apple with Outperform rating, $295 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2019